In accordance to Art. 106, paragraph 4 of Legislative Decree 17 March 2020 (“Cure Italy Decree”) converted by Law no. 27/2020, as  extended by Art. 3, paragraph 10-undiecies Law Decree 29 December 2022, no. 198, converted with amendments by Law 24 February 2023, n. 14, the participation in the Shareholders’ Meeting of those who are entitled to vote will take place exclusively through the shareholder representative designated by the Company pursuant to Art. 135-undecies of Legislative Decree 24 February 1998 no. 58 (the “Consolidated Law”) (the “Designated Representative”).

The participation of the authorised persons in the Shareholders’ Meeting (i.e. the members of the corporate bodies, the Secretary and the Designated Representative) may also take place using telecommunication equipment with the procedures communicated to them individually, in compliance with the regulatory provisions applicable for this eventuality.

Please note that electronic vote and/or vote by mail shall not be allowed.